STEM-03. WAVE1 KNOCKDOWN ENHANCES THE ANTITUMOR EFFICACY IN PRIMARY GLIOBLASTOMA NEUROSPHERES

INTRODUCTION: Despite multi-model therapies that include maximal surgical resection, radiation, chemotherapy, and tumor treating fields, the median survival of Glioblastoma (GBM) patients is around 15 months. WASP-family verprolin homologous protein 1 (WAVE1) is a downstream effector that receives s...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Autores principales: Namagiri, Sriya, Thammegowda, Shilpa, Sur, Hannah, Vézina, Amélie, Chowdhury, Ashis, Maric, Dragan, Gangaplara, Arunakumar, Edwards, Nancy, Jackson, Sadhana, Ray-Chaudhury, Abhik, Heiss, John, Banasavadi-Siddegowda, Yeshavanth Kumar
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2020
Materias:
Cancer Stem Cells
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651572/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.820
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares